DAE HWA Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 19 shareholders own 32.58% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.74%	Jun-Jin Ko	1,706,867	₩21.1b	0%	no data
9.71%	Soo-Ji Kim	1,700,000	₩21.0b	-10.5%	no data
4.91%	Kim Woon-Jang	860,157	₩10.6b	13.1%	no data
3.39%	Han-Koo Lee	593,300	₩7.3b	-4.51%	no data
1.71%	Samsung Asset Management Company, Ltd.	298,850	₩3.7b	0%	0.01%
1.13%	Kim Eun-Seok	198,500	₩2.5b	0.35%	no data
0.43%	Dimensional Fund Advisors LP	76,178	₩940.8m	0%	no data
0.31%	Bongok Lee	55,000	₩679.3m	0%	no data
0.2%	Heejung Go	35,000	₩432.3m	0%	no data
0.19%	Sangsu Lee	33,500	₩413.7m	0%	no data
0.14%	Dohyun Lee	24,100	₩297.6m	0%	no data
0.13%	Yukyung Lee	23,000	₩284.0m	0%	no data
0.12%	Subin Lee	20,500	₩253.2m	0%	no data
0.12%	Minseung Kang	20,500	₩253.2m	0%	no data
0.12%	Suhyun Lee	20,500	₩253.2m	0%	no data
0.12%	Tae-Kyung Lee	20,160	₩249.0m	-34.5%	no data
0.11%	Suchan Lee	19,500	₩240.8m	0%	no data
0.0031%	LGT Capital Partners Ltd.	547	₩6.7m	0%	no data
0.0011%	Jae-Kwon Yang	190	₩2.3m	0%	no data